tiprankstipranks
Trending News
More News >
Nektar Therapeutics (NKTR)
NASDAQ:NKTR

Nektar Therapeutics (NKTR) Revenue

Compare
1,597 Followers

Nektar Therapeutics Revenue

Nektar Therapeutics had a revenue of 21.81M in the quarter ending Dec 31, 2025, with 84.96%. This bring the company's revenue in the last twelve months to 55.23M, Increased -11.77%. In the fiscal year ending Dec 31, 2025, Nektar Therapeutics had annual revenue of 55.23M with -43.89% growth.
Revenue (ttm)
55.23M
Revenue Growth
-32.79%
P/S Ratio
38.98
Revenue/Employee
$905,443
Employees
61
Market Cap
$2.15B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
55.23M-43.20M-43.89%
Dec 31, 2024
98.43M8.30M+9.22%
Dec 31, 2023
90.12M-1.93M-2.10%
Dec 31, 2022
92.06M-9.85M-9.67%
Dec 31, 2021
101.91M-51.01M-33.36%
Dec 31, 2020
152.91M38.30M+33.41%
Dec 31, 2019
114.62M-1.08B-90.40%
Dec 31, 2018
1.19B885.61M+287.81%
Dec 31, 2017
307.71M